AbbVie Inc. Stock Outperforms Market On Strong Trading Day

Meta Platforms Inc

Change company Symbol lookup

Select an option...

META Meta Platforms Inc

RES RPC Inc

WOWI Metro One Telecommunications Inc

PDD Pinduoduo Inc

VIV Telefonica Brasil SA

EXPR Express Inc

KVSC Khosla Ventures Acquisition III Co

BWV Blue Water Vaccines Inc

ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund

LGO Largo Inc

Communication Services : Interactive Media & Services | Large Cap Value

Company profile

Meta Platforms Inc., formerly Facebook, Inc., builds technologies that help people find communities and grow businesses. The Company's products enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality (VR) headsets, wearables, and in-home devices. The Company operates through two segments: Family of Apps (FoA) and Reality Labs (RL). FoA includes Facebook, Instagram, Messenger, WhatsApp, and other services. RL includes augmented and virtual reality-related consumer hardware, software, and content. Facebook enables people to connect, share, discover and communicate with each other on mobile devices and personal computers. Instagram is a place where people can express themselves through photos, videos, and private messaging, and connect with and shop from their favorite businesses and creators. Messenger is a messaging application for people to connect with friends, family, groups, and businesses across platforms and devices.

AbbVie Inc. Stock Outperforms Market On Strong Trading Day

4:33 pm ET November 17, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of AbbVie Inc. (ABBV) inched 0.19% higher to $152.16 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.31% to 3,946.56 and Dow Jones Industrial Average falling 0.02% to 33,546.32. AbbVie Inc. closed $23.75 below its 52-week high ($175.91), which the company achieved on April 8th.

The stock underperformed when compared to some of its competitors Thursday, as Pfizer Inc. (PFE) rose 0.58% to $48.33, Eli Lilly & Co. (LLY) rose 2.22% to $360.77, and AstraZeneca PLC ADR (AZN.LN) rose 0.41% to $64.06. Trading volume (4.9 M) remained 860,777 below its 50-day average volume of 5.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 17, 2022.

(END) Dow Jones Newswires

November 17, 2022 16:33 ET (21:33 GMT)